Consumer wearable devices with ECG capabilities can be useful in diagnosing previously unidentified paroxysmal atrial fibrillation.
May facilitate early AF identification via wearables; leaves open need for validation before clinical adoption.
Consumer rhythm-monitoring devices, such as the Apple Watch, are becoming more readily available. Irregular pulses can be detected using an optical sensor that is built into the wearable device. The Apple Watch (Apple Inc., Cupertino, CA, USA) is a class II medical device with pulse rate and electrocardiography (ECG) monitoring capabilities. Here, we report a case in which an arrhythmia that was conventionally perceived but undiagnosed was identified as an atrial fibrillation by the self-acquisition of the ECG data using an Apple Watch.
No takes yet. Share an insight, caveat, or question.
Hirota et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: